(Post-pandemic Era) - Global Point of Care (PoC) Molecular Diagnostics Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Publisher Name :
Date: 21-Oct-2020
No. of pages: 80

Summary

This study analysis was given on a worldwide scale, for instance, present and historical Point of Care (PoC) Molecular Diagnostics growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Point of Care (PoC) Molecular Diagnostics production, Point of Care (PoC) Molecular Diagnostics revenue, Point of Care (PoC) Molecular Diagnostics consumption and Point of Care (PoC) Molecular Diagnostics price.

According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. XYZResearch published a report for global Point of Care (PoC) Molecular Diagnostics market in this environment.

In terms of revenue, this research report indicated that the global Point of Care (PoC) Molecular Diagnostics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Point of Care (PoC) Molecular Diagnostics industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments.

The ????Bayer Corporation aims at producing XX Point of Care (PoC) Molecular Diagnostics in 2020, with XX % production to take place in global market, ????Roche Diagnostics accounts for a volume share of XX %.

At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Point of Care (PoC) Molecular Diagnostics Market by XYZResearch Include

- NorthAmerica

- Asia

- Europe

- Middle East & Africa

- South America

Competitive Analysis; Who are the Major Players in Point of Care (PoC) Molecular Diagnostics Market?

- Bayer Corporation

- Roche Diagnostics

- Sysmex Corporation

- Abaxis

- Abbott Laboratories

- BioMerieux SA

- Bio-Rad Laboratories

- Danaher Corporation

- OraSure Technologies

Major Type of Point of Care (PoC) Molecular Diagnostics Covered in XYZResearch report:

- Polymerase Chain Reaction (Real Time PCR)

- In Situ Hybridization

- Chips and Microarrays

- Mass Spectrometry

- Sequencing

- Isothermal Amplification

- Others

Application Segments Covered in XYZResearch Market

- Hospitals

- Diagnostic Laboratories

- Research & Academic Laboratories

For any other requirements, please feel free to contact us and we will provide you customized report.

(Post-pandemic Era) - Global Point of Care (PoC) Molecular Diagnostics Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Table of Contents

Global Point of Care (PoC) Molecular Diagnostics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Polymerase Chain Reaction (Real Time PCR) -Product Introduction and Major Manufacturers
1.1.2 In Situ Hybridization -Product Introduction and Major Manufacturers
1.1.3 Chips and Microarrays -Product Introduction and Major Manufacturers
1.1.4 Mass Spectrometry -Product Introduction and Major Manufacturers
1.1.5 Sequencing -Product Introduction and Major Manufacturers
1.1.6 Isothermal Amplification -Product Introduction and Major Manufacturers
1.1.7 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Type
3.1 Global Point of Care (PoC) Molecular Diagnostics Production by Type (2015-2026)
3.2 Global Point of Care (PoC) Molecular Diagnostics Revenue by Type (2015-2026)
3.3 North America Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
3.4 Asia Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
3.5 Europe Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
3.7 South America Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
4 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Application
4.1 Historical & Forecast Global Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
5 North America
5.1 US Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Point of Care (PoC) Molecular Diagnostics Average Price Trend
10.1 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in North America (2015-2026)
10.2 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Asia (2015-2026)
10.3 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Europe (2015-2026)
10.4 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in South America (2015-2026)
11 Value Chain (Impact of COVID-19)
11.1 Point of Care (PoC) Molecular Diagnostics Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Point of Care (PoC) Molecular Diagnostics Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Point of Care (PoC) Molecular Diagnostics Competitive Analysis
12.1 Bayer Corporation
12.1.1 Bayer Corporation Company Profiles
12.1.2 Bayer Corporation Product Introduction
12.1.3 Bayer Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Company Profiles
12.2.2 Roche Diagnostics Product Introduction
12.2.3 Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Sysmex Corporation
12.3.1 Sysmex Corporation Company Profiles
12.3.2 Sysmex Corporation Product Introduction
12.3.3 Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Abaxis
12.4.1 Abaxis Company Profiles
12.4.2 Abaxis Product Introduction
12.4.3 Abaxis Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 OraSure Technologies
12.5.1 Abbott Laboratories Company Profiles
12.5.2 Abbott Laboratories Product Introduction
12.5.3 Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 BioMerieux SA
12.6.1 BioMerieux SA Company Profiles
12.6.2 BioMerieux SA Product Introduction
12.6.3 BioMerieux SA Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Company Profiles
12.7.2 Bio-Rad Laboratories Product Introduction
12.7.3 Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Danaher Corporation
12.8.1 Danaher Corporation Company Profiles
12.8.2 Danaher Corporation Product Introduction
12.8.3 Danaher Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 OraSure Technologies
12.9.1 OraSure Technologies Company Profiles
12.9.2 OraSure Technologies Product Introduction
12.9.3 OraSure Technologies Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
13 Conclusion

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Point of Care (PoC) Molecular Diagnostics Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table Regional Market Share in Terms of Production (2019-2026)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure Global Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure Global Point of Care (PoC) Molecular Diagnostics Production Market Share (%) by Type (2019 -2020)
Table Global Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure Global Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Point of Care (PoC) Molecular Diagnostics Revenue Market Share (%) by Type (2019-2020)
Figure North America Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure North America Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure North America Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure North America Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure Asia Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure Asia Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure Asia Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure Europe Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure Europe Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure Europe Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Point of Care (PoC) Molecular Diagnostics Production (K Unit) by Type (2015-2026)
Figure South America Point of Care (PoC) Molecular Diagnostics Production (K Unit) and Growth Rate (2015-2026)
Figure South America Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Type (2015-2026)
Figure South America Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2015-2026)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure North America Point of Care (PoC) Molecular Diagnostics Consumption (K Unit) and Growth Rate (2015-2026)
Figure North America Point of Care (PoC) Molecular Diagnostics Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure Asia Point of Care (PoC) Molecular Diagnostics Consumption (K Unit) and Growth Rate (2015-2026)
Figure Asia Point of Care (PoC) Molecular Diagnostics Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure Europe Point of Care (PoC) Molecular Diagnostics Consumption (K Unit) and Growth Rate (2015-2026)
Figure Europe Point of Care (PoC) Molecular Diagnostics Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Consumption (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Point of Care (PoC) Molecular Diagnostics Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Figure South America Point of Care (PoC) Molecular Diagnostics Consumption (K Unit) and Growth Rate (2015-2026)
Figure South America Point of Care (PoC) Molecular Diagnostics Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Point of Care (PoC) Molecular Diagnostics Different Application Field Consumption (K Unit)
Table US Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Point of Care (PoC) Molecular Diagnostics Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in China
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in EU
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in USA
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in Japan
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in India
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Point of Care (PoC) Molecular Diagnostics in South America
Figure Value Chain Structure of Point of Care (PoC) Molecular Diagnostics
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Point of Care (PoC) Molecular Diagnostics
Figure Cost Structure of Point of Care (PoC) Molecular Diagnostics in 2020
Table Distributors/Traders List
Table Bayer Corporation Profiles
Table Bayer Corporation Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Bayer Corporation Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bayer Corporation SWOT Analysis
Table Roche Diagnostics Profiles
Table Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Roche Diagnostics SWOT Analysis
Table Sysmex Corporation Profiles
Table Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Sysmex Corporation SWOT Analysis
Table Abaxis Profiles
Table Abaxis Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Abaxis Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Abaxis SWOT Analysis
Table Abbott Laboratories Profiles
Table Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Abbott Laboratories Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Abbott Laboratories SWOT Analysis
Table BioMerieux SA Profiles
Table BioMerieux SA Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure BioMerieux SA Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure BioMerieux SA SWOT Analysis
Table Bio-Rad Laboratories Profiles
Table Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bio-Rad Laboratories SWOT Analysis
Table Danaher Corporation Profiles
Table Danaher Corporation Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure Danaher Corporation Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Danaher Corporation SWOT Analysis
Table OraSure Technologies Profiles
Table OraSure Technologies Point of Care (PoC) Molecular Diagnostics Product Introduction
Figure OraSure Technologies Point of Care (PoC) Molecular Diagnostics Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs